Similar medications and substitutes for TRASTUZUMAB-DKST
In short: Ogivri (TRASTUZUMAB-DKST) belongs to the HER2/neu Receptor Antagonist class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Ogivri is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Ogivri in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.